Vol 2011, No 1 (2011)

Table of Contents

Research & Development

GlaxoSmithKline Forms US$650 M Epigenetics Alliance with Epizyme Abstract
Heather Cartwright
Pfizer Licenses Seattle Genetics’ Antibody-Drug Conjugate Technology Abstract
Heather Cartwright
Merck Serono and Domain Therapeutics Partner to Develop Positive Allosteric Modulators for Parkinson’s Disease Abstract
Heather Cartwright
Theraclone Sciences Signs its First Major Antibody Deal with Pfizer Abstract
Heather Cartwright

Licensing

Oncolys Out-Licenses Phase II HIV Drug to Bristol-Myers Squibb Abstract
Heather Cartwright
Xoma Partners with Servier to Develop and Commercialise its Lead Anti-Inflammatory Drug Abstract
Heather Cartwright

Mergers & Acquisitions

Reckitt Benckiser to Acquire India’s Paras Pharmaceuticals for US$725 M Abstract
Heather Cartwright
Gilead Strengthens its Early-Stage Pipeline by Acquiring Arresto Biosciences Abstract
Heather Cartwright
Biogen Idec Expands its Neurology Pipeline by Acquiring Three Programmes from Neurimmune Abstract
Heather Cartwright
Biotie Therapies Expands CNS Pipeline with Acquisition of Synosia Therapeutics Abstract
Heather Cartwright

Joint Venture

Sanofi-aventis Forms Covalent Drug Discovery Partnership with Avila Therapeutics in Oncology Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.